BNP Paribas Financial Markets’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-12,433
| Closed | -$129K | – | 5119 |
|
|
2022
Q2 | $129K | Sell |
12,433
-160,275
| -93% | -$1.19M | ﹤0.01% | 3269 |
|
|
2022
Q1 | $1.53M | Buy |
172,708
+103,600
| +150% | +$786K | ﹤0.01% | 2014 |
|
|
2021
Q4 | $478K | Buy |
69,108
+60,489
| +702% | +$887K | ﹤0.01% | 3028 |
|
|
2021
Q3 | $107K | Buy |
8,619
+6,849
| +387% | +$98.7K | ﹤0.01% | 3246 |
|
|
2021
Q2 | $32.3K | Sell |
1,770
-6,463
| -79% | -$129K | ﹤0.01% | 3407 |
|
|
2021
Q1 | $172K | Buy |
8,233
+2,152
| +35% | +$45.4K | ﹤0.01% | 3110 |
|
|
2020
Q4 | $109K | Sell |
6,081
-4,517
| -43% | -$67.8K | ﹤0.01% | 3168 |
|
|
2020
Q3 | $120K | Buy |
10,598
+3,623
| +52% | +$44.8K | ﹤0.01% | 3018 |
|
|
2020
Q2 | $95.1K | Sell |
6,975
-20,706
| -75% | -$285K | ﹤0.01% | 2786 |
|
|
2020
Q1 | $360K | Buy |
27,681
+21,347
| +337% | +$381K | ﹤0.01% | 2544 |
|
|
2019
Q4 | $128K | Sell |
6,334
-1,781
| -22% | -$43.2K | ﹤0.01% | 3170 |
|
|
2019
Q3 | $209K | Buy |
8,115
+2,560
| +46% | +$62.7K | ﹤0.01% | 2722 |
|
|
2019
Q2 | $135K | Sell |
5,555
-3,926
| -41% | -$85.8K | ﹤0.01% | 2851 |
|
|
2019
Q1 | $189K | Buy |
9,481
+8,407
| +783% | +$153K | ﹤0.01% | 2740 |
|
|
2018
Q4 | $17.7K | Sell |
1,074
-1,287
| -55% | -$21.7K | ﹤0.01% | 3144 |
|
|
2018
Q3 | $42K | Buy |
2,361
+199
| +9% | +$4.5K | ﹤0.01% | 3117 |
|
|
2018
Q2 | $63.7K | Sell |
2,162
-6,182
| -74% | -$195K | ﹤0.01% | 3011 |
|
|
2018
Q1 | $300K | Buy |
8,344
+245
| +3% | +$8.85K | ﹤0.01% | 2544 |
|
|
2017
Q4 | $257K | Buy |
8,099
+241
| +3% | +$7.56K | ﹤0.01% | 2831 |
|
|
2017
Q3 | $303K | Buy |
7,858
+942
| +14% | +$37K | ﹤0.01% | 2251 |
|
|
2017
Q2 | $313K | Buy |
6,916
+2,093
| +43% | +$80K | ﹤0.01% | 2170 |
|
|
2017
Q1 | $186K | Sell |
4,823
-511
| -10% | -$21.4K | ﹤0.01% | 2245 |
|
|
2016
Q4 | $203K | Buy |
5,334
+2,666
| +100% | +$127K | ﹤0.01% | 2198 |
|
|
2016
Q3 | $144K | Buy |
2,668
+1,445
| +118% | +$73.4K | ﹤0.01% | 1912 |
|
|
2016
Q2 | $44.9K | Buy |
+1,223
| New | +$43.2K | ﹤0.01% | 2333 |
|
|
2016
Q1 | – | Sell |
-6,832
| Closed | -$420K | – | 3211 |
|
|
2015
Q4 | $420K | Buy |
6,832
+39
| +0.6% | +$2.46K | ﹤0.01% | 1467 |
|
|
2015
Q3 | $471K | Buy |
6,793
+4,359
| +179% | +$303K | ﹤0.01% | 1392 |
|
|
2015
Q2 | $165K | Buy |
2,434
+2,268
| +1,366% | +$106K | ﹤0.01% | 1807 |
|
|
2015
Q1 | $6.83K | Buy |
+166
| New | +$7.46K | ﹤0.01% | 2972 |
|
Other funds holding RDUS
BNP Paribas Financial Markets's RDUS Position: Q3 2022 in Review
BNP Paribas Financial Markets sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 12,433 shares — an estimated $129K sold.
BNP Paribas Financial Markets first reported a position in RDUS in Q1 2015 and held it in 29 quarters. The position peaked at $1.53M in Q1 2022. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- BNP Paribas Financial Markets reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- BNP Paribas Financial Markets sold 12,433 Radius Health, Inc. shares in Q3 2022, an estimated $129K.
- BNP Paribas Financial Markets first reported a position in Radius Health, Inc. in Q1 2015 and held it in 29 quarters.
- BNP Paribas Financial Markets's Radius Health, Inc. position peaked at $1.53M in Q1 2022.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2022, filed 15 Nov 2022.